HARBOUR INVESTMENTS, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$24,845
-3.5%
1,606
-2.0%
0.00%0.0%
Q2 2023$25,749
+265.1%
1,639
+282.9%
0.00%
Q1 2023$7,053
-9.2%
428
-14.1%
0.00%
Q4 2022$7,769
+11.0%
4980.0%0.00%
Q3 2022$7,0000.0%4980.0%0.00%
Q2 2022$7,000
+16.7%
498
+17.5%
0.00%
Q4 2021$6,000
-91.8%
424
-90.5%
0.00%
-100.0%
Q3 2021$73,000
-6.4%
4,440
-4.6%
0.00%0.0%
Q2 2021$78,000
-3.7%
4,652
+4.8%
0.00%
-33.3%
Q1 2021$81,0004,4400.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders